| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.001 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |